Thousands of lawsuits over baby formula should stay where filed, court says
The Appellate Court of Illinois' 5th District upheld, opens new tab a lower court's ruling rejecting Abbott and Mead Johnson's motions to transfer the lawsuits out of Madison County, Illinois. The decision allows the claims to move forward in what is often viewed as a plaintiff-friendly county court. Madison County is often flagged by tort reform groups as a jurisdiction known for outsize jury verdicts against corporate defendants.
The appellate court, however, reversed the lower court's ruling denying the companies' separate motion to transfer or dismiss the lawsuits based on their argument that the cases were filed in an inconvenient location. The appeals court sent that ruling back to the lower court for reconsideration.
A representative for Mead Johnson said in a statement that the company will continue to pursue dismissal of the cases in Madison County, many of which don't involve Mead Johnson products or injuries that occurred in the county. The representative said that plaintiffs' lawyers were trying to "coerce settlement by building a large inventory of claims, even when plaintiffs' lawyers have no intention of ever trying them,' the company said.
A spokesperson for Abbott Laboratories did not respond to a request for comment.
Tor Hoerman, one of the attorneys for the plaintiffs said in a statement that the ruling "reinforces the importance of corporate accountability and helps ensure that families impacted by these tragic injuries can seek justice in the appropriate forum."
All of the lawsuits allege that the companies failed to warn that their specialized formulas used by newborn intensive care units in hospitals could cause necrotizing enterocolitis, a disease that almost exclusively affects premature infants and has an estimated mortality rate of more than 20%.
The companies have denied the claims, saying that while breast milk protects against NEC, formula does not cause it, and that the benefits of breast milk have long been known to clinicians.
In addition to state court cases in Illinois, Missouri and Pennsylvania, a federal multidistrict litigation with more than 700 cases over the claims is moving forward in Chicago, according to court records.
The same Illinois appeals court is also considering a similar dispute over transferring more cases over the preterm formula that are currently pending in St. Clair County, Illinois, another court targeted by tort reformers for being plaintiff-friendly.
In 2024, a jury in St. Clair County ordered Mead Johnson to pay $60 million to the mother of a premature baby who died after being fed the company's Enfamil baby formula. A few months later, a St. Louis, Missouri, jury ordered Abbott to pay $495 million in damages in another case.
Both companies prevailed in the most recent trial, in October. However, the judge in that case in March ordered a new trial, finding that lawyers for the defendants had acted improperly.
The case is Jupiter v. Mead Johnson and Co LLC, Appellate Court of Illinois, Fifth District, No. 230248.
For the plaintiffs: Ashley Keller and Benjamin Whiting of Keller Postman; Tor Hoerman of TorHoerman Law; and David Cates of Cates Law Firm
For Abbott Laboratories: Linda Coberly and Stephen D'Amore of Winston & Strawn; Thomas Kilbride and Adam Vaught of Kilbride & Vaught; and W. Jason Rankin and Emilee Bramstedt of HeplerBroom
For Mead Johnson: Joel Bertocchi of Akerman; Anthony Anscombe and Darlene Alt of Steptoe & Johnson; and Donald Flack of Bartholomew, Shevlin & Flack
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Reuters
an hour ago
- Reuters
Roche to test if new drug can prevent Alzheimer's disease, Bloomberg News reports
July 27 (Reuters) - Swiss drugmaker Roche Holding (ROG.S), opens new tab plans to test whether an experimental medicine can prevent Alzheimer's disease symptoms in high-risk people, Bloomberg News reported on Sunday. The new late-stage study will target people who are at risk of cognitive decline and aim to slow down the emergence of symptoms or prevent them fully, the report said, citing a statement. The new pre-clinical study is the third largest late-stage trial that the company has announced for its drug trontinemab, which uses an experimental technology called brain shuttle to ferry medicine past the protective blood-brain barrier, according to the report. Rivals like Eli Lilly (LLY.N), opens new tab have been making progress in the complicated field of Alzheimer's recently with Lilly's Alzheimer's drug Kisunla getting recommendation from the European Medicines Agency (EMA) last week. Reuters could not immediately verify the report. Roche did not immediately respond to a request for a comment. Treatments for Alzheimer's approved so far, including Eisai (4523.T), opens new tab and Biogen's (BIIB.O), opens new tab Leqembi, and Eli Lilly's Kisunla, are designed to clear sticky clumps of a protein called amyloid beta in the brain. They also carry hefty price tags and the risk of serious brain swelling and bleeding.
Daily Mail
2 hours ago
- Daily Mail
Hospital begs for help identifying woman who has been in their care for past 100 days
A Manhattan hospital is begging for the public's help in identifying a woman who was admitted more than 100 days ago. On April 12 around 4:45am, a woman believed to be in her late-fifties was sitting at a Harlem bus stop when a bystander dialed 911. It is unclear why an ambulance was called, but she was taken to Mount Sinai in Morningside Heights - where she has remained ever since. Employees have described the mysterious patient, who may go by the name Pam, as shy. In a photo shared by the hospital, she was seen covering her face with a towel. But these surface-level details are all officials have gathered about Pam during her three months at the hospital, and now hospital workers are trying to fill in the gaps. The hospital is asking anyone with information on who she might be to come forward, NBC reported. Pam is 5'8" tall and weighs 170 pounds. Hospital workers believe she was often in the Harlem area and generally wore black and covered her face. She speaks English and has greying hair. The Daily Mail has reached out to Mount Sinai for comment. Anyone with information regarding Pam's identity should contact the hospital's associate director of social work Kelly LaTerra at 646-901-9309. Last month, a California man was found unconscious and was rushed to St. Mary Medical Center in Long Beach. He was believed to be in his mid-forties, but just as in Pam's case, little else was known about the patient. A chilling photo released by Dignity Health showed the man lying in a hospital bed, hooked up to a ventilator. In October 2024, another California hospital took a similar approach to Mount Sinai in hopes of identifying a seriously ill patient. Staff at the Riverside Community Hospital had done everything they could think of, but could not determine the name of a man who came through the facility's doors a month earlier. They refused to say what was wrong with him or why he was attached to a ventilator, but released a photograph in the hopes that someone can put a name to the face. Identifying John or Jane Doe patients is no easy task, as doctors and other hospital staff members must work to find out who they are without violating their rights. The New York Department of Health has protocols in place specifically for missing children, college students and vulnerable adults. These standards were set in 2018 after 'several instances of a missing adult with Alzheimer's disease who was admitted to a hospital as an unidentified patient and police and family members were unable to locate the individual.' However, the process is not as cut and dry when it is the hospital asking for the public's help instead of the other way around. While hospitals have been known to share images of unknown patients when all else fails, they are not allowed to reveal much about their circumstances.
The Guardian
3 hours ago
- The Guardian
Top medical body concerned over RFK Jr's reported plans to cut preventive health panel
A top US medical body has expressed 'deep concern' to Robert F Kennedy Jr over news reports that the health secretary plans to overhaul a panel that determines which preventive health measures including cancer screenings should be covered by insurance companies. The letter from the the American Medical Association comes after the Wall Street Journal reported on Friday that Kennedy plans to overhaul the 40-year old US Preventive Services Task Force because he regards them as too 'woke', according to sources familiar with the matter. During his second term, Donald Trump has frequently raged against organizations and government departments that he considers too liberal – often without any evidence. The US president, and his cabinet members such as Kennedy, have also overseen huge cuts and job losses across the US government. The taskforce is made up of a 16-member panel appointed by health and human services secretaries to serve four-year terms. In addition to cancer screenings, the taskforce issues recommendations for a variety of other screenings including osteoporosis, intimate partner violence, HIV prevention, as well as depression in children. Writing in its letter to Kennedy on Sunday, the AMA defended the panel, saying: 'As you know, USPSTF plays a critical, non-partisan role in guiding physicians' efforts to prevent disease and improve the health of patients by helping to ensure access to evidence-based clinical preventive services.' 'As such, we urge you to retain the previously appointed members of the USPSTF and commit to the long-standing process of regular meetings to ensure their important work can be continued without disruption,' it added. Citing Kennedy's own slogan of 'Making America healthy again,' the AMA went on to say: 'USPSTF members have been selected through an open, public nomination process and are nationally recognized experts in primary care, prevention and evidence-based medicine. They serve on a volunteer basis, dedicating their time to help reduce disease and improve the health of all Americans – a mission well-aligned with the Make America Healthy Again initiative.' According to the Affordable Care Act, public and private insurance companies must cover any services recommended by the Preventive Services Task Force without cost sharing. In a statement to MedPage Today, Department of Health and Human Services spokesperson Andrew Nixon did not confirm the reports, instead saying: 'No final decision has been made on how the USPSTF can better support HHS' mandate to Make America Healthy Again.' Reports of Kennedy's alleged decision to overhaul the taskforce come after the American Conservative published an essay earlier this month that described the taskforce as advocating for 'leftwing ideological orthodoxy'. It went on to accuse the panel of being 'packed with Biden administration appointees devoted to the ideological capture of medicine', warning that the 'continued occupation of an important advisory body in HHS – one that has the capacity to force private health insurers to cover services and procedures – by leftwing activists would be a grave oversight by the Trump administration'. In response to the essay, 104 health organizations, including the American Medical Association, issued a separate letter to multiple congressional health committees in which they urged the committees to 'protect the integrity' of the taskforce. 'The loss of trustworthiness in the rigorous and nonpartisan work of the Task Force would devastate patients, hospital systems, and payers as misinformation creates barriers to accessing lifesaving and cost effective care,' the organizations said. In June, Kennedy removed all 17 members of a US Centers for Disease Control and Prevention panel of vaccine experts. Writing in a Wall Street Journal op-ed, he accused the committee of having too many conflicts of interest. Kennedy's decision to overhaul the immunization panel was met with widespread criticism from health experts, with the American Public Health Association executive director Georges Benjamin calling the ouster 'a coup'. 'It's not how democracies work. It's not good for the health of the nation,' Benjamin said.
